×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS53 Application of RWD to Clinical Development: Discussion with Industry, Regulatory, and Academia Through Hypothetical Case Studies
Session Chair(s)
Takashi Moriya, PhD, MBA
Director, VEO Vaccines Value Evidence and Outcomes, Japan MA
GlaxoSmithKline K.K., Japan
Speaker(s)
Yoshifumi Ukyo
Janssen Pharmaceutical K.K., Japan
Associate Director, Statistics & Decision Sciences
Junichi Asano, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Statistical Reviewer
Shogo Nomura, PhD
The University of Tokyo, Japan
Statistician, Department of Biostatistics
Have an account?